Literature DB >> 32575867

Myoferlin Is a Yet Unknown Interactor of the Mitochondrial Dynamics' Machinery in Pancreas Cancer Cells.

Sandy Anania1,2, Raphaël Peiffer1,2, Gilles Rademaker1,2, Alexandre Hego3, Marc Thiry4, Louise Deldicque5, Marc Francaux5, Naïma Maloujahmoum1, Ferman Agirman1, Akeila Bellahcène1, Vincent Castronovo1, Olivier Peulen1,2.   

Abstract

Pancreas ductal adenocarcinoma is one of the deadliest cancers where surgery remains the main survival factor. Mitochondria were described to be involved in tumor aggressiveness in several cancer types including pancreas cancer. We have previously reported that myoferlin controls mitochondrial structure and function, and demonstrated that myoferlin depletion disturbs the mitochondrial dynamics culminating in a mitochondrial fission. In order to unravel the mechanism underlying this observation, we explored the myoferlin localization in pancreatic cancer cells and showed a colocalization with the mitochondrial dynamic machinery element: mitofusin. This colocalization was confirmed in several pancreas cancer cell lines and in normal cell lines as well. Moreover, in pancreas cancer cell lines, it appeared that myoferlin interacted with mitofusin. These discoveries open-up new research avenues aiming at modulating mitofusin function in pancreas cancer.

Entities:  

Keywords:  mitochondria; mitofusin; myoferlin; pancreas cancer

Year:  2020        PMID: 32575867     DOI: 10.3390/cancers12061643

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  5 in total

Review 1.  Divergent Roles of Mitochondria Dynamics in Pancreatic Ductal Adenocarcinoma.

Authors:  Cristian Andres Carmona-Carmona; Elisa Dalla Pozza; Giulia Ambrosini; Andrea Errico; Ilaria Dando
Journal:  Cancers (Basel)       Date:  2022-04-26       Impact factor: 6.575

Review 2.  The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells.

Authors:  Yibo Fu; Francesca Ricciardiello; Gang Yang; Jiangdong Qiu; Hua Huang; Jianchun Xiao; Zhe Cao; Fangyu Zhao; Yueze Liu; Wenhao Luo; Guangyu Chen; Lei You; Ferdinando Chiaradonna; Lianfang Zheng; Taiping Zhang
Journal:  Cells       Date:  2021-02-25       Impact factor: 6.600

3.  Myoferlin targeting triggers mitophagy and primes ferroptosis in pancreatic cancer cells.

Authors:  Gilles Rademaker; Yasmine Boumahd; Raphaël Peiffer; Sandy Anania; Tom Wissocq; Maude Liégeois; Géraldine Luis; Nor Eddine Sounni; Ferman Agirman; Naïma Maloujahmoum; Pascal De Tullio; Marc Thiry; Akeila Bellahcène; Vincent Castronovo; Olivier Peulen
Journal:  Redox Biol       Date:  2022-05-04       Impact factor: 10.787

4.  Paladin, overexpressed in colon cancer, is required for actin polymerisation and liver metastasis dissemination.

Authors:  Vincent Castronovo; Olivier Peulen; Gilles Rademaker; Brunella Costanza; Sébastien Pyr Dit Ruys; Raphaël Peiffer; Ferman Agirman; Naïma Maloujahmoum; Didier Vertommen; Andrei Turtoi; Akeila Bellahcène
Journal:  Oncogenesis       Date:  2022-07-26       Impact factor: 6.524

5.  Myoferlin disturbs redox equilibrium to accelerate gastric cancer migration.

Authors:  Hailong Shi; Yuanyuan Cheng; Qimei Shi; Wenzhi Liu; Xue Yang; Shuang Wang; Lin Wei; Xiangming Chen; Hao Fang
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.